Published: 12 February 2024
Author(s): Yu Zhang, Yinong Chen, Hong Chen, Chunling Dong, Xiaoyun Hu, Xiaomao Xu, Ling Zhu, Zhe Cheng, Dingyi Wang, Zhu Zhang, Wanmu Xie, Jun Wan, Peiran Yang, Shengfeng Wang, Chen Wang, Zhenguo Zhai, CURES investigators
Issue: May 2024
Section: Original Article

Acute pulmonary embolism (PE) can be life-threatening in certain situations. Recent epidemiological data suggest that PE can affect approximately 300,000 patients and may result in 60,000 to 100,000 deaths per year in the United States [1,2]. According to two studies that focused on European populations, the 30-day all-cause mortality for non-high-risk PE could be up to 5.1 % and 7.8 %, respectively [3,4]. Our previous data from the China pUlmonary REgistry Study (CURES) demonstrated that 2.9 % of non-high-risk patients died in the hospital [5].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.